1327 results found.
BONESUPPORT Signs Strategic U.S. Agreement with Collagen Matrix
BONESUPPORT entered into an agreement with Collagen Matrix on U.S. sales of bone graft substitute products throu...
Orthocell Gains EU Patent for Tissue Regeneration Technology
Orthocell was granted an additional European patent for its CelGro® collagen device for soft tissue regenera...
Ortho RTi Allowed Second European Patent for Ortho-R Technology
Ortho Regenerative Technologies received a Notice of Allowance from the EU Patent Office, which will protect the f...
BONESUPPORT Shifting to Direct Sales in US
BONESUPPORT will create its own U.S. commercial organization to support current and future U.S. product launches. Direct sales will commence in
Wright Medical Announces 1Q18 Revenue
Wright Medical reported 1Q18 revenue of US $198.5MM, +12.0% from 1Q17.
Alphatec Announces 1Q18 Revenue
Alphatec reported 1Q18 revenue of US $21.3MM, -23.9% vs. 1Q17.
Xtant Medical Posts 1Q18 Revenue
Xtant Medical posted 1Q18 revenue of US $17.9MM, -18.8% vs. 1Q17.
K2M Reports 1Q18 Revenue
K2M posted 1Q18 revenue of US $67.9MM, +9.6% vs. 1Q17, and increased its full-year guidance range to $283MM-$287MM fol...
Globus Medical Posts 1Q18 Revenue
Globus Medical reported 1Q18 revenue of US $174.4MM, +11.9% vs. 1Q17, and raised its full-year guidance to $695MM
NuVasive Posts 1Q18 Revenue
NuVasive reported 1Q18 revenue of US $260.5MM, +4.6% vs. 1Q17.
Vericel Posts MACI 1Q18 Revenue Growth
For 1Q18, Vericel posted orthobiologic revenue of US $12.1MM, +142% vs. 1Q17.
Anika Therapeutics Reports 1Q18 Orthobiologic Revenue
Anika Therapeutics posted 1Q18 orthobiologic revenue of US $19.5MM, -3.6% vs. 1Q17.
DePuy Synthes, Prosidyan Partner on FIBERGRAFT Products
DePuy Synthes entered into an exclusive agreement to promote Prosidyan's FIBERGRAFT® synthetic bone graft in spina...
SeaSpine 1Q18 Revenue Grows 4% YoY
SeaSpine announced 1Q18 revenue of US $33.2MM, +4.1% vs. 1Q17.
Orthofix Posts 1Q18 Revenue Growth of 6% YoY
Orthofix posted 1Q18 revenue of US $108.7MM, +5.8% vs. 1Q17.
Stryker Posts 1Q18 Revenue
ORTHOWORLD estimates Stryker’s 1Q18 orthopaedic revenue at US $1,724.9MM, +7.0% from 1Q17. 
Zimmer Biomet Reports 1Q18 Orthopaedic Revenue
ORTHOWORLD estimates Zimmer Biomet 1Q18 orthopaedic revenue of US $1,856.6MM, +2.2% vs. 1Q17.
Kuros Biosciences Receives CE Mark Approval for MagnetOs Putty
Kuros Biosciences received CE Mark approval for MagnetOs Putty bone void filler.
Biologica Technologies Presents Update on ProteiOS Growth Factor
Biologica Technologies is debuting initial clinical data from spinal applications using ProteiOS...
DiscGenics Treats First Patient in IDCT Trial
The first patient has been treated in DiscGenics' Phase I/II U.S. clinical trial of IDCT injection to treat
Fidia Presents HYMOVIS Viscosupplement Study Data
Studies indicate that Fidia's HYMOVIS® viscosupplement enhanced cartilage volume and thickness in patients suffering from symptomatic ...
Datum Orthobiologics to Develop New Biomaterials
Datum Orthobiologics has formed to develop bio-programmable collagen-based biomaterials with musculoskeletal applications.
DePuy Synthes Reports 1Q18 Orthopaedic Revenue
DePuy Synthes reported 1Q18 orthopaedic revenue of US $2,250.0MM, -1.1% vs. 1Q17.
AlloSource and Stryker Launch ProChondrix CR Allograft
AlloSource and distribution partner Stryker launched ProChondrix® CR cryopreserved osteochondral allogr...
RTI Surgical Reaches Milestone for Sterilization Processes
RTI Surgical reached a global milestone of >8 million biologic implants processed through proprietary steriliz...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2018 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group